Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.

Autor: Elliott VA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America., Rychahou P; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America; Department of Surgery, University of Kentucky, Lexington, Kentucky, United States of America., Zaytseva YY; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America., Evers BM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America; Department of Surgery, University of Kentucky, Lexington, Kentucky, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2014 May 13; Vol. 9 (5), pp. e97432. Date of Electronic Publication: 2014 May 13 (Print Publication: 2014).
DOI: 10.1371/journal.pone.0097432
Abstrakt: Background: Liver metastasis is the most common cause of death in patients with colorectal cancer. Despite extensive research into the biology of cancer progression, the molecular mechanisms that drive colorectal cancer metastasis are not well characterized.
Methods: HT29 LM1, HT29 LM2, HT29 LM3 cell lines were derived from the human colorectal cancer cell line HT29 following multiple rounds of in vivo selection in immunodeficient mice.
Results: CD44 expression, a transmembrane glycoprotein involved in cell-cell and cell-matrix adhesions, and cancer cells adhesion to endothelial cells was increased in all in vivo selected cell lines, with maximum CD44 expression and cancer cells adhesion to endothelial cells in the highly metastatic HT29 LM3 cell line. Activation of c-Met upon hepatocyte growth factor (HGF) stimulation in the in vivo selected cell lines is CD44 independent. In vitro separation of CD44 high and low expression cells from HT29 LM3 cell line with FACS sorting confirmed that c-Met activation is CD44 independent upon hepatocyte growth factor stimulation. Furthermore, in vivo evaluation of CD44 low and high expressing HT29 LM3 cells demonstrated no difference in liver metastasis penetrance.
Conclusions: Taken together, our findings indicate that the aggressive metastatic phenotype of in vivo selected cell lines is associated with overexpression of CD44 and activation of c-MET. We demonstrate that c-Met activation is CD44 independent upon hepatocyte growth factor stimulation and confirm that CD44 expression in HT29 LM3 cell line is not responsible for the increase in metastatic penetrance in HT29 LM3 cell line.
Databáze: MEDLINE
Externí odkaz: